Clinical trial NCT05409079: Schulze Muscular Dystrophy Ability Clinical Study
Official title: Schulze Muscular Dystrophy Ability Clinical Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Muscular Dystrophies
Spinal Muscular Atrophy
Duchenne Muscular Dystrophy
Limb Girdle Muscular Dystrophy
FSHD
Cerebral Palsy
Becker Muscular Dystrophy
Lead sponsor: AbiliTech Medical Inc.
Sponsor class: INDUSTRY
Collaborators: name: Richard M. Schulze Family Foundation
First posted: 2022-06-08
Enrollment: 35
Sex: ALL
Minimum age (years): 10
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The primary objective of the Schulze study is to evaluate the function of the upper limbs of subjects diagnosed with neuromuscular disorders, with and without use of the Abilitech Assist device in the clinic and home environments. Functional outcomes will include documenting active range of motion and the ability to perform activities of daily living (ADLs) using the standardized Canadian Occupational Performance Measure (COPM) and the Role Evaluation of Activities of Life (REAL) assessments. Secondary objectives are to assess the safety record and report on adverse events (AEs) and parameters related to device usage, including device usage time and the time required to don/doff the device. Secondary objectives also include characterization of user upper limb performance based on etiology.


Eligibility criteria: Inclusion Criteria:

1. Subjects between 10 and 99 years of age, with onset of neuromuscular conditions that cause quadriparesis
2. MMT score of 1-3 in the elbow, wrist and hand; and a MMT score of 2-3 in the shoulder of at least one of the subject's arms
3. Ability of subject to raise their forearm off of their lap or laptray
4. Willingness to comply and participate with the study protocol and attend the study sessions
5. Ability to communicate verbally and respond to questions and commands
6. Ability to provide informed consent
7. Selected for participation based on investigator discretion

Exclusion Criteria:

1. Use of invasive ventilator
2. Open wounds or chronic pressure sores on upper extremities, neck, back or torso
3. Significantly unstable upper extremity joints
4. Unhealed bone fractures in the upper extremities
5. Active rotator cuff tear, grade 2 or 3
6. Surgical fixations limiting full passive range of motion
7. Uncontrolled upper-limb spasticity that significantly limits normal range of motion
8. Uncontrollable pain in the neck, shoulders or upper limbs
9. Ability to fully raise both hands simultaneously above their head with ease as defined by the investigator
10. Lack passive shoulder abduction of 120 degrees
11. Lack 90 degrees of passive elbow extension
12. Unable to follow instructions
13. Exhibit significant behavioral problems
14. Inability to provide consent

Primary outcomes:
measure: Canadian Occupational Performance Measure (COPM)
timeFrame: Change from Baseline before device intervention (30 days), and after device intervention (60 days)
measure: Roll Evaluation of Activities of Life (REAL) assessment
timeFrame: Change from Baseline before device intervention (30 days), and after device intervention (60 days)
Secondary outcomes:
Other outcomes:
Locations:
city: Saint Paul
country: United States
facility: Gillette Children's
state: Minnesota
Study officials:
References: